Publications by authors named "Elisabeth E Fransen van de Putte"

Claim this Profile
I
Indications and Outcomes for Deferred Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Combination Therapy: Can Systemic Therapy be Withdrawn in Patients with No Evidence of Disease?
Elisabeth E Fransen van de Putte, Luna van den Brink, Mohamed A Mansour, Johannes C van der Mijn, Sofie Wilgenhof

Eur Urol Open Sci· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urothelial Carcinoma in Bladder Diverticula: A Multicenter Analysis of Characteristics and Clinical Outcomes.
Charlotte S Voskuilen, Roland Seiler, Michael Rink, Cédric Poyet, Aidan P Noon, Elisabeth E Fransen van de Putte

Eur Urol Focus· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of the York Mason Procedure with and without Concomitant Graciloplasty to Treat Iatrogenic Rectourethral Fistulas.
Maarten J van der Doelen, Elisabeth E Fransen van de Putte, Simon Horenblas, John P F A Heesakkers

Eur Urol Focus· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer.
Roland Seiler, Ewan A Gibb, Natalie Q Wang, Htoo Zarni Oo, Hung-Ming Lam, Elisabeth E Fransen van de Putte

Clin Cancer Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent Radiotherapy and Panitumumab after Lymph Node Dissection and Induction Chemotherapy for Invasive Bladder Cancer.
Elisabeth E Fransen van de Putte, Floris Pos, Barry Doodeman, Bas W G van Rhijn, Elsbeth van der Laan

J Urol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non-muscle-invasive bladder cancer.
Elisabeth E Fransen van de Putte, Judith Bosschieter, Theo H van der Kwast, Simone Bertz, Stefan Denzinger

BJU Int· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reproducibility and Prognostic Performance of the 1973 and 2004 World Health Organization Classifications for Grade in Non-muscle-invasive Bladder Cancer: A Multicenter Study in 328 Bladder Tumors.
Judith Bosschieter, Anouk Hentschel, C Dilara Savci-Heijink, J Patrick van der Voorn, Lawrence Rozendaal, Elisabeth E Fransen van de Putte

Clin Genitourin Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate sparing cystectomy for bladder cancer: A two-center study.
Charlotte S Voskuilen, Elisabeth E Fransen van de Putte, Jose I Pérez-Reggeti, Erik van Werkhoven, Laura S Mertens

Eur J Surg Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endo-Urological Techniques for Benign Uretero-Ileal Strictures Have Poor Efficacy and Affect Renal Function.
Elisabeth E Fransen van de Putte, Liesbeth L de Wall, Erik van Werkhoven, Eddi A Heldeweg, Axel Bex

Urol Int· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metric substage according to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancer.
Elisabeth E Fransen van de Putte, Wolfgang Otto, Arndt Hartmann, Simone Bertz, Roman Mayr

Urol Oncol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose dense MVAC prior to radical cystectomy: a real-world experience.
Homayoun Zargar, Jay B Shah, Elisabeth E Fransen van de Putte, Kylea R Potvin, Kamran Zargar-Shoshtari

World J Urol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.
Roland Seiler, Hussam Al Deen Ashab, Nicholas Erho, Bas W G van Rhijn, Brian Winters, Elisabeth E Fransen van de Putte

Eur Urol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smooth Muscle Endothelin B Receptors Regulate Blood Pressure but Not Vascular Function or Neointimal Remodeling.
Eileen Miller, Alicja Czopek, Karolina M Duthie, Nicholas S Kirkby, Elisabeth E Fransen van de Putte

Hypertension· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variations in pelvic lymph node dissection in invasive bladder cancer: A Dutch nationwide population-based study during centralization of care.
Tom Johannes Noël Hermans, Elisabeth Ernestine Fransen van de Putte, Laurent Marie Constant Leo Fossion, Erik van Werkhoven, Rob Henricus Andreas Verhoeven

Urol Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended pelvic lymph node dissection at radical cystectomy for bladder cancer improves survival: Results of a nationwide population-based study.
Tom Johannes Noël Hermans, Elisabeth Ernestine Fransen van de Putte, Simon Horenblas, Bas Wilhelmus Gerardus van Rhijn, Rob Henricus Andreas Verhoeven

Int J Urol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy.
Wilhelmina C M Duivenvoorden, Siamak Daneshmand, Daniel Canter, Yair Lotan, Peter C Black, Elisabeth E Fransen van de Putte

J Urol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based study.
Tom J N Hermans, Elisabeth E Fransen van de Putte, Simon Horenblas, Richard P Meijer, Joost L Boormans

Eur J Cancer· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated Derived Neutrophil-to-Lymphocyte Ratio Corresponds With Poor Outcome in Patients Undergoing Pre-Operative Chemotherapy in Muscle-Invasive Bladder Cancer.
Kim E M van Kessel, Lorraine M de Haan, Elisabeth E Fransen van de Putte, Bas W G van Rhijn, Ronald de Wit

Bladder Cancer· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis.
Ming Yin, Monika Joshi, Richard P Meijer, Michael Glantz, Sheldon Holder, Elisabeth E Fransen van de Putte

Oncologist· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Relevance of Incidental Prostatic Lesions on FDG-Positron Emission Tomography/Computerized Tomography-Should Patients Receive Further Evaluation?
Daan J Reesink, Elisabeth E Fransen van de Putte, Erik Vegt, Jeroen De Jong, Erik van Werkhoven

J Urol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine/cisplatin.
Elisabeth E Fransen van de Putte, Laura S Mertens, Richard P Meijer, Michiel S van der Heijden, Axel Bex

World J Urol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative treatment and radical cystectomy for bladder cancer--a population based trend analysis of 10,338 patients in the Netherlands.
Tom J N Hermans, Elisabeth E Fransen van de Putte, Simon Horenblas, Valery Lemmens, Katja Aben

Eur J Cancer· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymph node count at radical cystectomy does not influence long-term survival if surgeons adhere to a standardized template.
Elisabeth E Fransen van de Putte, Tom J N Hermans, Erik van Werkhoven, Laura S Mertens, Richard P Meijer

Urol Oncol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of substage and WHO classification systems in T1 urothelial carcinoma of the bladder.
Elisabeth E Fransen van de Putte, Mark A Behrendt, Garry L S Pigot, Theo H van der Kwast, Bas W G van Rhijn

Curr Opin Urol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Eliezer M. Van Allen, Levi A. Garraway and Jonathan E. Rosenberg's Letter to the Editor re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014.
Floris H Groenendijk, Elisabeth E Fransen van de Putte, Bas W G van Rhijn, René Bernards, Michiel S van der Heijden

Eur Urol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis